Search

Your search keyword '"Mazur, Grzegorz"' showing total 86 results

Search Constraints

Start Over You searched for: Author "Mazur, Grzegorz" Remove constraint Author: "Mazur, Grzegorz" Database Supplemental Index Remove constraint Database: Supplemental Index
86 results on '"Mazur, Grzegorz"'

Search Results

3. Identification of novel genetic loci for risk of multiple myeloma by functional annotation

4. Impact of Junction Length on Supercurrent Resilience against Magnetic Field in InSb-Al Nanowire Josephson Junctions

5. Realization of a minimal Kitaev chain in coupled quantum dots

6. A polysomnographic study on the relationship between sleep bruxism intensity and sleep quality.

9. A polygenic risk score for multiple myeloma risk prediction

10. A polysomnographic study on the relationship between sleep bruxism intensity and sleep quality

11. Singlet and triplet Cooper pair splitting in hybrid superconducting nanowires

12. Cardiac and vascular disorders as paraoccupational diseases -a Polish perspective.

13. Związek pomiędzy zaburzeniem lękowym z napadami lęku a nadciśnieniem tętniczym. Przegląd piśmiennictwa.

16. Soft Selection Rules for Femtosecond Pump–Probe Vibrational Coherence Spectroscopy

17. Properties of Coherent Vibrational Wavepackets Critically Depend on the Method of Their Generation

18. The cardiovascular health score and the volume of carotid body in computed tomography angiography in patients with arterial hypertension.

19. Role of the Lymphatic System in the Pathogenesis of Hypertension in Humans.

20. High expression of CC chemokine receptor 5 (CCR5) promotes disease progression in patients with B-cell non-Hodgkin lymphomas.

21. Breast cancer and synchronous multiple myeloma as a diagnostic challenge: Case report and review of literature.

22. The influence of hypertension on daytime sleepiness in obstructive sleep apnea.

24. Nieinterwencyjne badanie oceniające odpowiedź na leczenie u pacjentów z przewlekłą białaczką limfocytową (CLL) w zależności od zastosowanego schematu rytuksymab-chemioterapia

27. Comparison of the renal hyperemic effects of papaverine and dopamine in patients with renal artery stenosis.

28. Automatized Parameterization of DFTB Using Particle Swarm Optimization

29. Automatized Parameterization of the Density‐functional Tight‐binding Method. II. Two‐center Integrals

32. Charge-Transfer States in Pentacene: Dimer versus Crystal

33. Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia.

34. EFFICIENT ENERGY AND ELECTROSTATIC PROPERTIES CALCULATIONS AT THE MP2 THEORY LEVEL: A CASE STUDY OF DENSITY MATRIX-BASED COMPUTATIONAL QUANTUM CHEMISTRY.

35. EFFECTIVE RESOURCE ALLOCATION IN PARALLEL QUANTUM-CHEMICAL CALCULATIONS.

36. ANALYSIS OF THE BASIC IMPLEMENTATION ASPECTS OF HARDWARE-ACCELERATED DENSITY FUNCTIONAL THEORY CALCULATIONS.

37. ABCC3 and GSTM5 gene polymorphisms affect overall survival in Polish acute myeloid leukaemia patients.

38. A neural-network controlled dynamic evolutionary scheme for global molecular geometry optimization

39. IFN Gamma Gene Polymorphism May Contribute to the Susceptibility to CLL

40. IFN-γ promoter gene polymorphism in psoriasis vulgaris

41. Advances in the treatment of indolent lymphomas

42. Increased expression of vascular endothelial growth factor (VEGF) in bone marrow of patients with myeloproliferative disorders (MPD)

43. Charge-pair states in organic molecular crystals: localized vs. delocalized description

44. Band gap and binding energies of charge-transfer excitons in organic molecular crystals

45. Quantum chemical valence indices from the one-determinantal difference approach

46. Malignant melanoma with gall bladder metastasis as a second neoplasm in the course of prostate cancer

47. Increased angiogenesis in cutaneous T-cell lymphomas

49. Five-Year Follow-up of Safety and Efficacy of a Phase III Randomized Trial of Ofatumumab Therapy Versus Physicians' Choice in Patients with Bulky Fludarabine Refractory Chronic Lymphocytic Leukemia

50. Five-Year Follow-up of Safety and Efficacy of a Phase III Randomized Trial of Ofatumumab Therapy Versus Physicians' Choice in Patients with Bulky Fludarabine Refractory Chronic Lymphocytic Leukemia

Catalog

Books, media, physical & digital resources